Antara Capital LP Neogenomics Inc Transaction History
Antara Capital LP
- $26 Million
- Q4 2024
A detailed history of Antara Capital LP transactions in Neogenomics Inc stock. As of the latest transaction made, Antara Capital LP holds 250,000 shares of NEO stock, worth $2.78 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$2.78 Million% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$218 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$158 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$72.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$68.4 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$68.3 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.4B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...